Coyni, Inc. - Quarter Report: 2009 March (Form 10-Q)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
10-Q
|
[X]
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 For the quarterly period ended March 31,
2009
|
|
[
] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 For the transition period from _ to
_
|
Commission
file number: 000-22711
BLUEGATE
CORPORATION
(Exact
name of registrant as specified in its charter)
Nevada
|
76-0640970
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
incorporation
or organization)
|
Identification
No.)
|
701
North Post Oak Road, Suite 600, Houston,Texas
|
77024
|
(Address
of principal executive offices)
|
(Zip
Code)
|
voice: 713-686-1100
|
fax: 713-682-7402
|
Issuer's
telephone number
|
Indicate
by check mark whether the registrant :(1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filings requirements for
the past 90 days. Yes [X] No [ ]
Indicate
by check mark whether the registrant has submitted electronically and posted on
its Web site, if any, every Interactive Data File required to be submitted and
posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or
for such shorter period that the registrant was required to submit and post such
files). Yes [ ] No [X]
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions in of “large accelerated filer,” “accelerated filer” and
“smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check
one):
Large
accelerated filer
|
[
]
|
Accelerated
filer
|
[
]
|
Non-accelerated
filer
|
[
]
|
Smaller
reporting company
|
[X]
|
Indicate
by check mark whether the Registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes [ ] No [X]
APPLICABLE
ONLY TO CORPORATE ISSUERS
Indicate
the number of shares outstanding of each the issuer's classes of common stock,
as of the latest practicable date: 26,033,565 common shares outstanding as of
April 22, 2009.
TABLE OF CONTENTS
|
|
ITEM
1. FINANCIAL STATEMENTS
|
|
F-1
|
|
F-1
|
|
F-2
|
|
F-3
|
|
F-4
|
|
F-5
|
|
I-1
|
|
I-7
|
|
II-1
|
|
II-1
|
|
II-1
|
|
II-1
|
|
SIGNATURES
|
II-2
|
CERTIFICATIONS
|
II-3
|
CONSOLIDATED
BALANCE SHEETS
|
||||||||
UNAUDITED
|
||||||||
March
31,
|
December
31,
|
|||||||
2009
|
2008
|
|||||||
ASSETS
|
|
|||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 79,448 | $ | 11,283 | ||||
Accounts
receivable, net
|
484,581 | 502,631 | ||||||
Prepaid
expenses and other
|
19,197 | 22,498 | ||||||
Total
current assets
|
583,226 | 536,412 | ||||||
Property
and equipment, net
|
35,471 | 44,381 | ||||||
Total
assets
|
$ | 618,697 | $ | 580,793 | ||||
LIABILITIES AND STOCKHOLDERS’
DEFICIT
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable
|
$ | 246,535 | $ | 230,325 | ||||
Accounts
payable to related party
|
8,975 | 10,750 | ||||||
Accrued
liabilities
|
57,031 | 139,046 | ||||||
Notes
payable
|
12,800 | 12,800 | ||||||
Notes
payable to related parties
|
1,369,079 | 1,169,079 | ||||||
Accrued
liabilities to related parties
|
132,606 | 178,655 | ||||||
Deferred
revenue
|
194,709 | 194,472 | ||||||
Derivative
liabilities
|
175,000 | - | ||||||
Total
current liabilities
|
2,196,735 | 1,935,127 | ||||||
Stockholders’
deficit:
|
||||||||
Undesignated
preferred stock, $.001 par value, 9,999,952 shares authorized, none issued
and outstanding
|
- | - | ||||||
Series
C Convertible Non-Redeemable preferred stock, $.001 par value, 48 shares
authorized, issued and outstanding at March 31, 2009 and December 31,
2008; $12,500 per share liquidation preference ($600,000 aggregate
liquidation preference at March 31, 2009)
|
- | - | ||||||
Common
stock, $.001 par value, 50,000,000 shares authorized, 26,033,565 shares
issued and outstanding at March 31, 2009 and December 31,
2008
|
26,034 | 26,034 | ||||||
Additional
paid-in capital
|
21,642,704 | 26,240,785 | ||||||
Accumulated
deficit
|
(23,246,776 | ) | (27,621,153 | ) | ||||
Total
stockholders’ deficit
|
(1,578,038 | ) | (1,354,334 | ) | ||||
Total
liabilities and stockholders’ deficit
|
$ | 618,697 | $ | 580,793 | ||||
See
accompanying notes to consolidated financial statements
F-1
BLUEGATE CORPORATION
|
||||||||
CONSOLIDATED
STATEMENTS OF OPERATIONS
|
||||||||
THREE
MONTHS ENDED MARCH 31, 2009 AND 2008
|
||||||||
UNAUDITED
|
||||||||
2009
|
2008
|
|||||||
Service
revenue
|
$ | 1,013,955 | $ | 1,042,527 | ||||
Cost
of services
|
620,814 | 737,847 | ||||||
Gross
profit
|
393,141 | 304,680 | ||||||
Selling,
general and administrative expenses
|
145,370 | 260,217 | ||||||
Compensation
expense
|
252,176 | 1,106,191 | ||||||
Loss
from operations
|
(4,405 | ) | (1,061,728 | ) | ||||
Interest
expense
|
(67,650 | ) | (27,320 | ) | ||||
Other
income
|
21,432 | 2,228 | ||||||
Loss
on derivative financial instruments
|
(91,000 | ) | - | |||||
Net
loss
|
$ | (141,623 | ) | $ | (1,086,820 | ) | ||
Net
loss per common share - basic and diluted
|
$ | (0.00 | ) | $ | (0.05 | ) | ||
Basic
and diluted weighted average shares outstanding
|
26,033,565 | 21,523,235 | ||||||
See
accompanying notes to consolidated financial statements
F-2
BLUEGATE CORPORATION
|
||||||||||||||||||||||||||||
CONSOLIDATED
STATEMENT OF STOCKHOLDERS' DEFICIT
|
||||||||||||||||||||||||||||
THREE
MONTHS ENDED MARCH 31, 2009
|
||||||||||||||||||||||||||||
UNAUDITED
|
||||||||||||||||||||||||||||
ADDITIONAL
|
||||||||||||||||||||||||||||
COMMON
STOCK
|
PREFERRED
STOCK
|
PAID-IN
|
ACCUMULATED
|
|||||||||||||||||||||||||
SHARES
|
CAPITAL
|
SHARES
|
CAPITAL
|
CAPITAL
|
DEFICIT
|
TOTAL
|
||||||||||||||||||||||
Balance
at December 31, 2008
|
26,033,565 | $ | 26,034 | 48 | $ | - | $ | 26,240,785 | $ | (27,621,153 | ) | $ | (1,354,334 | ) | ||||||||||||||
Cumulative
effect of change in accounting principle - January 1, 2009
reclassification of embedded feature of equity-linked financial
instruments to derivative liabilities
|
(4,600,000 | ) | 4,516,000 | (84,000 | ) | |||||||||||||||||||||||
Common
stock options issued for employee services
|
1,919 | 1,919 | ||||||||||||||||||||||||||
Net
loss
|
(141,623 | ) | (141,623 | ) | ||||||||||||||||||||||||
Balance
at March 31, 2009
|
26,033,565 | $ | 26,034 | 48 | $ | - | $ | 21,642,704 | $ | (23,246,776 | ) | $ | (1,578,038 | ) |
See
accompanying notes to consolidated financial statements
F-3
BLUEGATE CORPORATION
|
||||||||
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
||||||||
THREE
MONTHS ENDED MARCH 31, 2009 AND 2008
|
||||||||
UNAUDITED
|
||||||||
2009
|
2008
|
|||||||
Cash
flows from operating activities:
|
||||||||
Net
loss
|
$ | (141,623 | ) | $ | (1,086,820 | ) | ||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||
Depreciation
and amortization
|
8,910 | 13,668 | ||||||
Common
stock options issued for employee services
|
1,919 | 147,206 | ||||||
Common
stock warrants issued to borrow funds from related party
|
- | 109,028 | ||||||
Common
stock issued for compensation
|
- | 535,500 | ||||||
Derivative
loss
|
91,000 | - | ||||||
Amortization
of debt issuance cost
|
20,000 | - | ||||||
Changes
in operating assets and liabilities:
|
||||||||
Accounts
receivable
|
18,050 | 80,108 | ||||||
Prepaid
expenses and other current assets
|
3,301 | 3,612 | ||||||
Accounts
payable and accrued liabilities
|
(65,805 | ) | (155,752 | ) | ||||
Accounts
payable to related party
|
(1,775 | ) | 3,521 | |||||
Accrued
liabilities to related parties
|
(46,049 | ) | 87,559 | |||||
Deferred
revenue
|
237 | 12,422 | ||||||
Net
cash used in operating activities
|
(111,835 | ) | (249,948 | ) | ||||
Cash
flows from investing activities:
|
||||||||
Purchase
of property and equipment
|
- | (9,370 | ) | |||||
Net
cash used in investing activities
|
- | (9,370 | ) | |||||
Cash
flows from financing activities:
|
||||||||
Proceeds
from related party short term debt
|
180,000 | 200,000 | ||||||
Payments
on related party short term debt
|
- | (39,602 | ) | |||||
Common
stock and warrants issued for cash
|
- | 95,000 | ||||||
Net
cash provided by financing activities
|
180,000 | 255,398 | ||||||
Net
increase (decrease) in cash and cash equivalents
|
68,165 | (3,920 | ) | |||||
Cash
and cash equivalents at beginning of period
|
11,283 | 43,703 | ||||||
Cash
and cash equivalents at end of period
|
$ | 79,448 | $ | 39,783 | ||||
Non
Cash Transactions:
|
||||||||
Issuance
of common stock for conversion of related party accounts payable, accrued
expenses and accrued interest
|
$ | - | $ | 305,000 | ||||
Derivative
liability at January 1, 2009
|
84,000 | - | ||||||
Supplemental
information:
|
||||||||
Cash
paid for interest
|
67,650 | 25,458 | ||||||
See
accompanying notes to consolidated financial statements
F-4
BLUEGATE CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
1. BASIS OF
PRESENTATION
The
accompanying unaudited interim financial statements of Bluegate Corporation,
have been prepared in accordance with accounting principles generally accepted
in the United States of America and the rules of the Securities and Exchange
Commission, and should be read in conjunction with the audited financial
statements and notes thereto contained in Bluegate's Annual Report filed with
the SEC on Form 10-K. In the opinion of management, all adjustments,
consisting of normal recurring adjustments, necessary for a fair presentation of
financial position and the results of operations for the interim periods
presented have been reflected herein. The results of operations for
interim periods are not necessarily indicative of the results to be expected for
the full year. Notes to the financial statements which substantially
duplicate the disclosure contained in the audited financial statements for
fiscal 2008 as reported in the Form 10-K have been omitted.
DERIVATIVE FINANCIAL
INSTRUMENTS
Bluegate
does not use derivative instruments to hedge exposures to
cash flow, market, or foreign currency risks. Bluegate
evaluates all of it financial instruments to determine if such instruments are
derivatives or contain features that qualify as embedded
derivatives. For derivative financial instruments that are
accounted for as liabilities, the derivative instrument is initially
recorded at its fair value and is then re-valued at each reporting date,
with changes in the fair value reported as charges or credits to
income. For option-based derivative financial instruments,
Bluegate uses the Black-Scholes option-pricing model to value the
derivative instruments at inception and subsequent valuation dates. The
classification of derivative instruments, including whether such
instruments should be recorded as liabilities or as equity, is re-assessed
at the end of each reporting period. Derivative
instrument liabilities are classified in the balance sheet as current or
non-current based on whether or not net-cash settlement of the derivative
instrument could be required within 12 months of the balance sheet
date.
FAIR VALUE MEASUREMENTS
In
September 2006, the FASB issued SFAS 157 which defines fair value, establishes a
framework for measuring fair value, and expands disclosures about fair value
measurements. The provisions of SFAS 157 were effective January 1, 2008.
The FASB has also issued Staff Position (FSP) SFAS 157-2 (FSP No. 157-2),
which delays the effective date of SFAS 157 for nonfinancial assets and
liabilities, except for items that are recognized or disclosed at fair value in
the financial statements on a recurring basis (at least annually), until fiscal
years beginning after November 15, 2008.
As
defined in SFAS 157, fair value is the price that would be received to sell an
asset or paid to transfer a liability in an orderly transaction between market
participants at the measurement date (exit price). The Company utilizes market
data or assumptions that market participants would use in pricing the asset or
liability, including assumptions about risk and the risks inherent in the inputs
to the valuation technique. These inputs can be readily observable, market
corroborated, or generally unobservable. The Company classifies fair value
balances based on the observability of those inputs. SFAS 157 establishes a fair
value hierarchy that prioritizes the inputs used to measure fair value. The
hierarchy gives the highest priority to unadjusted quoted prices in active
markets for identical assets or liabilities (level 1 measurement) and the lowest
priority to unobservable inputs (level 3 measurement).
The three
levels of the fair value hierarchy defined by SFAS 157 are as
follows:
Level 1 –
Quoted prices are available in active markets for identical assets or
liabilities as of the reporting date. Active markets are those in which
transactions for the asset or liability occur in sufficient frequency and volume
to provide pricing information on an ongoing basis. Level 1 primarily consists
of financial instruments such as exchange-traded derivatives, marketable
securities and listed equities.
Level 2 –
Pricing inputs are other than quoted prices in active markets included in level
1, which are either directly or indirectly observable as of the reported date.
Level 2 includes those financial instruments that are valued using models or
other valuation methodologies. These models are primarily industry-standard
models that consider various assumptions, including quoted forward prices for
commodities, time value, volatility factors, and current market and contractual
prices for the underlying instruments, as well as other relevant economic
measures. Substantially all of these assumptions are observable in the
marketplace throughout the full term of the instrument, can be derived from
observable data or are supported by observable levels at which transactions are
executed in the marketplace. Instruments in this category generally include
non-exchange-traded derivatives such as commodity swaps, interest rate swaps,
options and collars.
Level 3 –
Pricing inputs include significant inputs that are generally less observable
from objective sources. These inputs may be used with internally developed
methodologies that result in management’s best estimate of fair
value.
The
following table sets forth by level within the fair value hierarchy the
Company’s financial assets and liabilities that were accounted for at fair value
as of March 31, 2009. As required by SFAS 157, financial assets and
liabilities are classified in their entirety based on the lowest level of input
that is significant to the fair value measurement. The Company’s assessment of
the significance of a particular input to the fair value measurement requires
judgment, and may affect the valuation of fair value assets and liabilities and
their placement within the fair value hierarchy levels.
F-5
|
March 31,
2009
|
|||||||||||
|
Level
1
|
|
Level
2
|
|
Level 3
|
|
Total
|
|||||
Embedded
derivatives
|
|
-
|
|
$
|
175,000
|
|
-
|
|
$
|
175,000
|
||
|
|
|
|
The
derivatives listed above are carried at fair value. The fair value amounts in
current period earnings associated with the Company’s derivatives resulted from
Level 2 fair value methodologies; that is, the Company is able to value the
assets and liabilities based on observable market data for similar instruments.
This observable data includes the quoted market prices and estimated volatility
factors.
RECLASSIFICATIONS
We have
reclassified certain prior-year amounts to conform to the current year’s
presentation.
2. GOING CONCERN
CONSIDERATIONS
During
the three months ended March 31, 2009 and 2008, Bluegate has been unable to
generate cash flows sufficient to support its operations and has been dependent
on debt and equity raised from qualified individual investors. In addition to
negative cash flow from operations, Bluegate has experienced recurring net
losses, and has a negative working capital and shareholders’
deficit.
These
factors raise substantial doubt about the Company’s ability to continue as a
going concern. The consolidated financial statements do not include any
adjustments that might be necessary if Bluegate is unable to continue as a going
concern.
3.
|
NOTES
PAYABLE
|
Notes
payable at March 31, 2009 and December 31, 2008 are summarized
below:
|
3/31/2009
|
12/31/2008
|
||||||
|
|
|||||||
Unsecured notes
payable:
10%
note payable due upon demand
|
$ | 12,800 | $ | 12,800 | ||||
Notes
payable to related parties:
|
||||||||
Secured note payable to related
party: During 2007, the Company entered into a line of credit
agreement with SAI Corporation ("SAIC"), a corporation controlled by our
CEO, Stephen Sperco, to borrow up to $500,000. On February 28, 2008, the
line of credit agreement with SAIC was amended to increase the borrowing
to $700,000 and on February 28, 2008, Bluegate borrowed the additional
$200,000 from SAIC for working capital purposes. As condition to and as
additional consideration for SAIC’s agreement to lend the funds to the
Company, the Company granted SAIC a security interest in its assets as
more specifically detailed in the Promissory Note and Security Agreement,
and increased the interest rate from 12% to 15% per annum. On July 14,
2008, the line of credit agreement with SAIC was amended to increase the
borrowing to $900,000 and on July 31, 2008, Bluegate borrowed the
additional $200,000 from SAIC for working capital purposes. Upon Bluegate
borrowing the additional $200,000, the Company agreed to pay (1) SAIC a
$40,000 origination fee and (2) Sperco Technology Group, Inc. (“STG”), a
corporation controlled by our CEO, Stephen Sperco, all past due amounts
totaling $104,972. On August 14, 2008, the Company entered into a short
term unsecured loan with SAIC to meet its working capital needs to borrow
$65,000. Upon borrowing the $65,000, the Company agreed to pay SAIC a
$6,500 origination fee and to repay SAIC with the first available funds
once the August 15, 2008 payroll and medical insurance premium was paid.
The Company paid the $65,000 loan and $6,500 fee on August 15, 2008. On
August 28, 2008, the Company borrowed $50,000 from SAIC and agreed to pay
SAIC a $5,000 origination fee. The Company paid the $50,000 funds borrowed
and $5,000 fee on September 11, 2008. On October 16, 2008, the line of
credit agreement with SAIC was amended to increase the borrowing to
$1,100,000 and on October 21, 2008, Bluegate borrowed the additional
$200,000 from SAIC for working capital purposes. Upon Bluegate borrowing
the additional $200,000, the Company agreed to pay (1) SAIC a $20,000
origination fee and (2) Sperco Technology Group, Inc. all past due
amounts. On
February 23, 2009, the line of credit agreement with SAIC was amended to
increase the borrowing to $1,300,000 and on February 26, 2009, Bluegate
borrowed the additional $200,000 from SAIC for working capital purposes.
Upon Bluegate borrowing the additional $200,000, the Company agreed to pay
SAIC a $20,000 origination fee.
Note
payable to SAI Corporation due on demand
|
$ | 1,300,000 | $ | 1,100,000 | ||||
Unsecured notes payable to
related parties: During 2006, the Company entered into a line of
credit agreement with Manfred Sternberg ("MS"), Chief Strategy Officer and
William Koehler ("WK"), President and COO, for Bluegate to borrow up to
$500,000 from each of them. As of March 31, 2009, the interest rates on
the underlying credit cards pertaining to funds borrowed from MS and WK
were 17.24% and 17.23%, respectively.
|
||||||||
Notes
payable to William Koehler due on demand
|
34,628 | 34,628 | ||||||
Notes
payable to Manfred Sternberg due on demand
|
34,451 | 34,451 | ||||||
$ | 1,369,079 | $ | 1,169,079 |
F-6
4. EQUITY
TRANSACTIONS
During
the three months ended March 31, 2009, Bluegate completed the following equity
transactions:
Stock options issued for
services:
During
the three months ended March 31, 2009, Bluegate expensed $150 related to
previously issued stock options that vested during the period.
The
following table summarizes stock options issued to the employee during the three
months ended March 31, 2009:
Exercise
|
Fair
|
Expiration
|
Vesting
|
2009
|
|||||||||
Options
|
Price
|
Value
|
Date
|
Period
|
Expense
|
||||||||
50,000
|
$
|
0.10
|
$
|
1,769
|
3/4/2012
|
Immediately
|
$
|
1,769
|
As of
March 31, 2009, the company has outstanding: (i) 26,033,565 shares of common
stock; (ii) 17,437,800 warrants; (iii) 9,833,597 options; and, (iv) preferred
stock that are convertible into 1,200,000 shares of common stock, resulting on a
fully diluted basis, 54,504,962 shares of common stock. However, the company
currently has only 50,000,000 shares of common stock authorized by our Articles
of Incorporation. If all of the holders of warrants, options, convertible debt
and preferred stock requested to exercise or convert all of the warrants,
options, convertible debt and preferred stock, we would be unable to accommodate
4,504,962 shares of common stock in those requests. The company could have
liability in the future if an option holder, warrant holder, preferred stock
holder or holder of convertible debt desires to exercise or convert but cannot
because we do not have enough unissued common stock available for issuance.
However, the following individuals or entities have waived their reservation of
common stock underlying options and warrants until such time that the board of
directors deems the waiver is not necessary as follows: Stephen Sperco and
related entity (3,000,000 shares); Manfred Sternberg and related entities
(2,000,000 shares); and William Koehler (2,000,000 shares).
Bluegate
used the Black-Scholes option pricing model to value stock options and warrants
using the following assumptions: number of options as set forth in the option
agreements; no expected dividend yield; expected volatility ranging from 202% to
260%; risk-free interest rates of 5.0%; and expected terms based on the period
of time expected to elapse until exercise. When applicable, Bluegate uses the
simplified method of calculating expected term as described in SAB
107.
5. DERIVATIVE
LIABILITY
Embedded feature of
equity-linked financial instrument:
In June
2008, the FASB finalized EITF 07-5, "Determining Whether an Instrument (or
Embedded Feature) is indexed to an Entity's Own Stock". The EITF lays out a
procedure to determine if an equity-linked financial instrument (or embedded
feature) is indexed to its own common stock. The EITF is effective for fiscal
years beginning after December 15, 2008. 9,034,800 of Bluegate’s
outstanding warrants that were previously classified in equity were reclassified
to derivative liabilities on January 1, 2009 as a result of this EITF.
Bluegate estimated the fair value of these liabilities as of January 1, 2009 to
be $84,000 by recording a reduction of $4,600,000 to Additional Paid In Capital
and $4,516,000 to Accumulated Deficit. The effect of this adjustment
is recorded as a cumulative effect of change in accounting principle in our
consolidated statement of stockholders’ deficit. The fair value of these
liabilities was $175,000 at March 31, 2009. The $91,000 change in fair value is
reported in our consolidated statement of operations as a loss on derivative
financial instruments. The fair value of these liabilities will be re-measured
at the end of every reporting period and the change in fair value will be
reported in our consolidated statement of operations as a gain or loss on
derivative financial instruments.
Bluegate
used the Black-Scholes option pricing model to value the embedded feature of the
liability using the following assumptions: number of options as set forth in the
option agreements; no expected dividend yield; expected volatility ranging from
202% to 290%; risk-free interest rates of 5.0%; and expected terms based on the
contractual term.
F-7
FORWARD
LOOKING STATEMENT
This
Management's Discussion and Analysis of Financial Condition and Results of
Operations as of March 31, 2009 and for the three months then ended, should be
read in conjunction with the audited financial statements and notes thereto set
forth in our annual report on Form 10-K for 2008.
Certain
statements contained in this report, including, without limitation, statements
containing the words, "likely", "forecast", "project", "believe", "anticipate",
"expect", and other words of similar meaning, constitute "forward-looking
statements" within the meaning of Section 27A of the Securities Exchange Act of
1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause our actual results, performance
or achievements to be materially different from any future results, performance,
or achievements expressed or implied by such forward-looking statements. Given
these uncertainties, readers are cautioned not to place undue reliance on such
factors or to announce publicly the results of any revision of the
forward-looking statements contained or incorporated by reference herein to
reflect future events or developments. In addition to the forward-looking
statements contained in this Form 10-Q, the following forward-looking factors
could cause our future results to differ materially from our forward-looking
statements: competition, capital resources, credit resources, funding,
government compliance and market acceptance of our products and
services.
OUR
BUSINESS
Bluegate
provides the nation's only Medical Grade Network® that facilitates physician and
clinical integration between hospitals and physicians in a secure private
environment. As a leader in providing the Healthcare industry
outsourced Information Technology (IT) solutions and remote IT management
services, Bluegate provides hospitals and physicians with a single source
solution for all of their clinical integration and IT
needs. Additionally Bluegate provides IT and telecommunications
consulting through its professional services organization.
CONSULTING
PRACTICE
Healthcare
institutions have very unique requirements not found in a typical commercial
environment. Our Healthcare consulting practice works with medical
facilities and systems on evaluation, procurement and implementation of
healthcare related voice, data, video, infrastructure and applications for the
Healthcare environment with a particular emphasis on the deployment of
Electronic Medical Record applications. Our IT/Telecommunications consulting
practice works in various industry verticals providing evaluation, procurement
and implementation of IT/Telecommunications solutions for our
clients. Our Applications consulting practice provides specific
applications development, enhancement, coding, and integration work for various
industry verticals.
OUTSOURCING
Our
outsourcing offering includes help desk support and break-fix operations as well
as acquisition and special financing of equipment and services. It
also can include provisions for technology refresh, change management, and level
of service agreements. Our target market for such services consists
of private-practice physicians whose office staffs typically lack the in-house
technical expertise to support mission-critical computer systems and associated
hardware. In many cases, these private-practice physicians are
affiliated with our larger medical facility clients, creating a logical
foundation for Bluegate to establish and maintain long-term business
relationships.
SYSTEMS
INTEGRATION AND MANAGED SECURITY SOLUTIONS
Our
systems integration and managed security group enables secure, HIPAA-compliant
data communication between hospitals, medical facilities and physician practices
from all locations via the services of our Bluegate Medical Grade Network® -
ultimately enhancing patient care. We also provide affordable access to
compatible medical-focused content and applications over a secure IT
infrastructure to improve practice efficiency and service. We extend IT Best
Practices to the edge of the healthcare network ensuring every access point for
the physician and healthcare location is as secure as the hospital
itself.
MARKET
OPPORTUNITY IN HEALTHCARE
Electronic
data communication networks have vast potential for enhancing the quality of
patient care, mitigating the soaring costs of healthcare, and protecting patient
privacy. To harness this potential, the current administration,
Congress, and administrative agencies are advocating that all physicians get
connected to the proposed national health information network (NHIN)
system. A NHIN is expected to enable physicians to write electronic
prescriptions (eRx) and securely share patient electronic health records (EHR),
including medical images, with other healthcare providers at hospitals, clinics,
and individual physician offices.
I-1
In order
to access and use the NHIN, individual physicians must have the appropriate IT
environment at their offices, and the hospitals where they admit
patients. Further, the hospitals’ credentialed physicians must be on
a common HIPAA compliant network. Once the hospital has installed the
necessary secure electronic connectivity behind their firewall, the "last mile"
of connectivity, the figurative distance from the telecommunication provider's
switch to an end user (i.e. the physician), still presents a major
challenge. In addition to being HIPAA-compliant, the networks also
need to be interoperable, which requires assessing and augmenting physicians'
existing IT equipment and resources. Adequate training and technical
support is necessary to ensure the highest possible network availability and
security and the ability to move and manage information back and
forth.
The
Administrative Simplification provisions of Title II of HIPAA require the United
States Department of Health and Human Services to establish national standards
for electronic healthcare transactions and national identifiers for providers,
health plans, and employers. It also addresses the security and privacy of
health data. Adopting these standards will improve the efficiency and
effectiveness of the nation's Healthcare system by encouraging the widespread
use of electronic data interchange in Healthcare. As the result of
increasing pressure for healthcare providers to adopt electronic health records
and the favorable healthcare IT environment created by the Stark Law exceptions
there is rapidly increasing demand for Bluegate’s networks, technologies, remote
management, and professional IT services.
BLUEGATE
STRATEGY
Healthcare
Our
current short term strategies are to: (1) increase our market penetration of the
Houston hospital, centralized Healthcare, and physician markets; (2) commence
deployment of services in other Texas cities; and, (3) commence deployment of
services in other cities in the U.S. Our long term strategy is
fivefold: (1) fill as much of the national HIPAA-compliant secured
communications void that exists between the physician and the hospital as we
can; (2) sell our services to the physicians that utilize our Medical
Grade Network®, enabling them to choose Bluegate as their electronic health
solutions firm and as the IT outsource firm of choice for all of their
technology needs; (3) to be "THE" IT solutions resource to medical
institutions, Healthcare facilities, regional health information
organizations (RHIOs), and centralized Healthcare organizations (HCOs) for all
their IT needs; (4) partner with a wide array of third party providers of
software, managed systems, pharmacy benefits, and many other applications that
must run on electronic networks and be installed in hospitals, HCOs and medical
practices; and (5) become the premier “boutique” consulting practice supporting
the deployment of Electronic Medical Record systems and services.
Professional
Services
In
addition to the Professional Services initiatives in Healthcare, Bluegate
intends to continue to grow in the following areas through its Trilliant
Technology Group organization: (1) Further establish its reputation
as one of the top Telecommunications consulting organizations in the U.S.; and
(2) expand its IT Infrastructure consulting base.
COMPETITION
We are
not aware of any completely direct competitors at this time. However,
competition may include vendors of HIPAA software and Internet Protocol ("IP")
networks whose security may or may not comply with the terms of the HIPAA
confidentiality compliance requirements.
The IT
services market is extremely competitive, highly fragmented and has grown
dramatically in recent years. The market is characterized by the absence of
significant barriers to entry and rapidly changing applications and
technology. Other competitors may be:
-
|
Access
and content providers, such as AOL, Microsoft, EarthLink and Time
Warner;
|
-
|
Professional
Service organizations, such as IBM, CSC, Perot Systems, and
EDS;
|
-
|
Regional,
national and international telecommunications companies, such as AT&T,
Verizon, Qwest, and Sprint;
|
-
|
On-line
services offered by incumbent cable providers such as Comcast and
Cox;
|
-
|
DSL
providers such as the RBOC’s and
CLEC’s.
|
Most of
our competitors have more extensive resources than we have, and there is no
assurance that we will be able to successfully compete.
Our web
site is www.bluegate.com.
I-2
CRITICAL
ACCOUNTING POLICIES AND ESTIMATES
Our
discussion and analysis of our financial condition and results of operations are
based upon financial statements which have been prepared in accordance with
generally accepted accounting principles in the United States. The preparation
of these financial statements requires us to make estimates and judgments that
affect the reported amounts of assets, liabilities, revenue and expenses, and
related disclosure of contingent assets and liabilities. On an ongoing basis, we
evaluate these estimates. We base our estimates on historical experience and on
assumptions that are believed to be reasonable. These estimates and assumptions
provide a basis for making judgments about the carrying values of assets and
liabilities that are not readily apparent from other sources. Actual results may
differ from these estimates under different assumptions or conditions, and these
differences may be material.
We
believe that the following critical accounting policies affect our more
significant judgments and estimates used in the preparation of our consolidated
financial statements.
REVENUE
RECOGNITION
Revenue,
which includes licensing revenue, is recognized based upon contractually
determined monthly service charges to individual customers. Services
are billed in advance and, accordingly, revenues are deferred until the period
in which the services are provided.
STOCK-BASED
COMPENSATION
Financial
Accounting Standard No. 123, "Accounting for Stock-Based Compensation" ("SFAS
No. 123R") established financial accounting and reporting standards for
stock-based employee compensation plans. It defines a fair value
based method of accounting for an employee stock option or similar equity
instrument. In January 2006, we implemented SFAS No. 123R, and
accordingly, Bluegate accounts for compensation cost for stock option plans in
accordance with SFAS No. 123R.
DERIVATIVE FINANCIAL
INSTRUMENTS
Bluegate
does not use derivative instruments to hedge exposures to
cash flow, market, or foreign currency risks. Bluegate
evaluates all of it financial instruments to determine if such instruments are
derivatives or contain features that qualify as embedded
derivatives. For derivative financial instruments that are
accounted for as liabilities, the derivative instrument is initially
recorded at its fair value and is then re-valued at each reporting date,
with changes in the fair value reported as charges or credits to
income. For option-based derivative financial instruments,
Bluegate uses the Black-Scholes option-pricing model to value the
derivative instruments at inception and subsequent valuation dates. The
classification of derivative instruments, including whether such
instruments should be recorded as liabilities or as equity, is re-assessed
at the end of each reporting period. Derivative
instrument liabilities are classified in the balance sheet as current or
non-current based on whether or not net-cash settlement of the derivative
instrument could be required within 12 months of the balance sheet
date.
GOING
CONCERN
We remain
dependent on outside sources of funding for continuation of our operations. Our
independent registered public accounting firm included a going concern
qualification in their report dated April 9, 2009 (included in our annual report
on Form 10-K for the year ended December 31, 2008), which raises substantial
doubt about our ability to continue as a going concern.
During
the three months ended March 31, 2009 and 2008, we have been unable to generate
cash flows sufficient to support our operations and have been dependent on debt
and equity raised from qualified individual investors.
During
the three months ended March 31, 2009 and 2008, we experienced negative
financial results as follows:
Three Months Ended March
31,
|
||||||||
2009
|
2008
|
|||||||
Net
loss
|
$ | (141,623 | ) | $ | (1,086,820 | ) | ||
Negative
cash flow from operations
|
(111,835 | ) | (249,948 | ) | ||||
Negative
working capital
|
(1,613,509 | ) | (1,025,753 | ) | ||||
Stockholders'
deficit
|
(1,578,038 | ) | (959,751 | ) |
These
factors raise substantial doubt about our ability to continue as a going
concern. The financial statements contained herein do not include any
adjustments relating to the recoverability and classification of recorded asset
amounts or amounts and classification of liabilities that might be necessary
should we be unable to continue in existence. Our ability to continue
as a going concern is dependent upon our ability to generate sufficient cash
flows to meet our obligations on a timely basis, to obtain additional financing
as may be required, and ultimately to attain profitable
operations. However, there is no assurance that profitable operations
or sufficient cash flows will occur in the future.
We have
supported the above operations by: (1) raising additional operating cash through
the private sale of our preferred and common stock, (2) selling convertible debt
and common stock to certain key stockholders and (3) issuing stock and options
as compensation to certain employees and vendors in lieu of cash
payments.
I-3
These
steps have provided us with the cash flows to continue our business plan, but
have not resulted in significant improvement in our financial position. We are
considering alternatives to address our cash flow situation that include: (1)
raising capital through additional sale of our common stock and/or debt
Securities and (2) reducing cash operating expenses to levels that are in line
with current revenues.
These
alternatives could result in substantial dilution of existing stockholders.
There can be no assurance that our current financial position can be improved,
that we can raise additional working capital or that we can achieve positive
cash flows from operations. Our long-term viability as a going concern is
dependent upon
the
following:
|
-
Our ability to locate sources of debt or equity funding to meet current
commitments and near-term future
requirements.
|
|
-
Our ability to achieve profitability and ultimately generate sufficient
cash flow from operations to sustain our continuing
operations.
|
RESULTS
OF OPERATIONS
Three
Months Ended March 31,
|
Increase
(Decrease)
|
|||||||||||||||||||
2009
|
2008
|
2007
|
2009
from 2008
|
2008
from 2007
|
||||||||||||||||
Service
revenue
|
$ | 1,013,955 | $ | 1,042,527 | $ | 1,361,067 | $ | (28,572 | ) | $ | (318,540 | ) | ||||||||
Cost
of services
|
620,814 | 737,847 | 733,512 | (117,033 | ) | 4,335 | ||||||||||||||
Gross
profit
|
393,141 | 304,680 | 627,555 | 88,461 | (322,875 | ) | ||||||||||||||
Selling,
general and administrative expenses
|
145,370 | 260,217 | 867,459 | (114,847 | ) | (607,242 | ) | |||||||||||||
Compensation
expense
|
252,176 | 1,106,191 | 1,797,125 | (854,015 | ) | (690,934 | ) | |||||||||||||
Loss
from operations
|
(4,405 | ) | (1,061,728 | ) | (2,037,029 | ) | (1,057,323 | ) | (975,301 | ) | ||||||||||
Interest
expense
|
(67,650 | ) | (27,320 | ) | (39,177 | ) | 40,330 | (11,857 | ) | |||||||||||
Other
income
|
21,432 | 2,228 | - | 19,204 | 2,228 | |||||||||||||||
Loss
on derivative financial instruments
|
(91,000 | ) | - | - | (91,000 | ) | - | |||||||||||||
Net
loss
|
$ | (141,623 | ) | $ | (1,086,820 | ) | $ | (2,076,206 | ) | $ | (945,197 | ) | $ | (989,386 | ) | |||||
Service
Revenue.
The
$318,540 decrease in Service Revenue from 2007 to 2008 is primarily attributable
to: (1) a reduction of $325,000 related to the completion of certain large
application development engagements throughout 2007; (2) a reduction of $180,000
related to the fourth quarter 2007 decision by one of the healthcare systems
that we contracted with to provide managed security services to their
physicians, notified their physicians that effective January 1, 2008 they would
no longer subsidize those costs, which resulted in the reduction of the number
of physician practices we served for that system; (3) a reduction of $26,000
related to the reduction of EMR related projects and (4) offset by an increase
of $201,000 related to the implementation project management and consulting
services. The $28,572 decrease in Service Revenue from 2008 to 2009 is primarily
attributable to: (1) a reduction of $160,000 related to our Medical Grade
Network® business; (2) a reduction of $30,000 related to product sales and (3)
offset by an increase of $190,000 related to the implementation project
management and consulting services.
Cost of
Services.
The
$4,335 increase in Cost of Services from 2007 to 2008 is insignificant. The
$117,033 decrease in Cost of Services from 2008 to 2009 is primarily
attributable to: (1) a $70,000 decrease in personnel related to the completion
of certain large application development engagements and other cost cutting
measures; (2) a $90,000 decrease related to our Medical Grade Network® business;
and (2) offset by an increase of $45,000 related to technology consulting
services.
Gross
Profit.
Our Gross
Profit decreased $322,875 from 2007 to 2008 and increased $88,461 from 2008 to
2009. Our Gross Profit as a percentage of Service Revenue decreased from 46% in
2007 to 29% in 2008 and increased to 39% in 2009 primarily as a result of the
changes in the Service Revenue and Cost of Services as described
above.
Selling,
General and Administrative Expenses (SG&A).
The
$607,242 decrease in SG&A from 2007 to 2008 was due primarily to the
elimination of $590,000 related to business consulting and investment banking
fees, as well as the effects of additional cost control measures instituted
during the first quarter of 2008. The $114,847 decrease in SG&A from 2008 to
2009 is due primarily to the effects of additional cost control
measures.
I-4
Compensation
Expense.
|
|||
The
decrease in Compensation Expense of $690,934 from 2007 to 2008 is
principally comprised of the following:
|
|||
$ | (864,000 | ) |
decrease
related to options issued for employee services
|
(335,000 | ) |
decrease
related to changes in personnel
|
|
(136,000 | ) |
decrease
related to issuance of shares for employee compensation
|
|
519,000 |
increase
related to conversion of related party debt for common
stock
|
||
109,000 |
increase
related to warrants issued to borrow funds from a related
party
|
||
17,000 |
increase
related to related party purchase of common stock for
cash
|
||
The
decrease in Compensation Expense of $854,015 from 2008 to 2009 is
principally comprised of the following:
|
|||
$ | (519,000 | ) |
decrease
related to conversion of related party debt for common
stock
|
(145,000 | ) |
decrease
related to options issued for employee services
|
|
(109,000 | ) |
decrease
related to warrants issued to borrow funds from a related
party
|
|
(60,000 | ) |
decrease
related to a reduction in personnel
|
|
(17,000 | ) |
decrease
related to related party purchase of common stock for
cash
|
|
Interest
Expense.
The
$11,857 decrease in Interest Expense from 2007 to 2008 was insignificant. The
increase in Interest Expense of $40,330 from 2008 to 2009 was a result of the
increase in borrowings under the secured note payable to related
party.
Other
Income.
The
changes in other income from 2007 through 2009 are insignificant.
Loss on
Derivative Financial Instruments.
In June
2008, the FASB finalized EITF 07-5, "Determining Whether an Instrument (or
Embedded Feature) is indexed to an Entity's Own Stock". The EITF lays out a
procedure to determine if an equity-linked financial instrument (or embedded
feature) is indexed to its own common stock. The EITF is effective for fiscal
years beginning after December 15, 2008. Some of Bluegate’s outstanding
warrants that were previously classified in equity were reclassified to
derivative liabilities on January 1, 2009 as a result of this EITF.
Bluegate estimated the fair value of these liabilities as of January 1, 2009 to
be $84,000. The fair value of these liabilities was $175,000 at March 31,
2009. The $91,000 change in fair value is reported in our consolidated statement
of operations as a loss on derivative financial instruments.
Net
Loss.
The Net
Loss decreased $989,386 from 2007 to 2008 and decreased $945,197 from 2008 to
2009 primarily due to the decrease in Compensation Expense as detailed above, as
well as the changes in the Service Revenue, Cost of Services and SG&A as
described above.
FINANCIAL
CONDITION
Three
Months Ended March 31,
|
Increase
(Decrease)
|
|||||||||||||||||||
2009
|
2008
|
2007
|
2009
from 2008
|
2008
from 2007
|
||||||||||||||||
Net
cash (used in) operating activities
|
$ | (111,835 | ) | $ | (249,948 | ) | $ | (773,040 | ) | $ | (138,113 | ) | $ | (523,092 | ) | |||||
Net
cash (used in) investing activities
|
- | (9,370 | ) | (17,287 | ) | (9,370 | ) | (7,917 | ) | |||||||||||
Net
cash provided by financing activities
|
180,000 | 255,398 | 743,264 | (75,398 | ) | (487,866 | ) | |||||||||||||
Net
increase (decrease) in cash
|
$ | 68,165 | $ | (3,920 | ) | $ | (47,063 | ) | $ | 72,085 | $ | 43,143 | ||||||||
Cash
balance at end of period
|
$ | 79,448 | $ | 39,783 | $ | 209,058 | ||||||||||||||
Operating
Activities.
The net
decrease of $523,092 in cash used in operations from 2007 to 2008 is primarily
due to: (1) the decrease in personnel and related salaries as a result of: (i)
the completion of certain large application development engagements during 2007;
(ii) a decision by one of the healthcare systems that we contracted with to
provide managed security services to their physicians, notified their physicians
that effective January 1, 2008 they would no longer subsidize those costs, which
resulted in the reduction of the number of physician practices we served for
that system; (iii) the reduction of EMR related projects; (2) the elimination of
business consulting and investment banking fees and (3) partially offset by an
increase of personnel and salaries related to the implementation project
management and consulting services. The net decrease of $138,113 in cash used in
operations from 2008 to 2009 is primarily due to: (1) a decrease in personnel
related to the completion of certain large application development engagements;
(2) a reduction in product sales; (3) the effects of additional cost control
measures and (4) partially offset by an increase of personnel and salaries
related to the implementation project management and consulting
services.
I-5
Investing
Activities.
The
changes in the net cash used in investing activities from 2007 through 2009 are
insignificant.
Financing
Activities.
The
decrease of $487,866 in net cash provided by financing activities from 2007 to
2008 is due to: (1) a $305,000 decrease in investments in the company’s common
stock and warrants; (2) a $315,000 decrease in proceeds from a note payable from
an individual; and (3) a $132,000 net increase in related party short term debt.
The decrease of $75,398 in cash provided by financing activities from 2008 to
2009 is due to: (1) a $95,000 decrease in investments in the company’s common
stock and warrants; and (2) a $40,000 increase in payments on related party
short term debt.
FORECAST
FOR OUR CUSTOMER BASE
The
increased reliance on IT and Telecommunications to manage costs and deploy
enhanced business solutions has created an ideal business environment for
Bluegate in 2009 and beyond. This trend is particularly evident in
Healthcare where the roll-out of Electronic Medical Records and cost control
initiatives are National priorities; however, the current economic conditions
have resulted in projects being delayed or cancelled.
Bluegate
Services
At March
31, 2009, we had approximately 290 Medical Grade Network®
customers which we forecast will increase moderately this year. During
the second half of 2008 and first quarter of 2009, we continued greater focus on
more complex projects and applications, which resulted in more efficient use of
our resources and higher profit margins on the project work.
Professional
Services
In
October 2007 we were awarded a contract with a healthcare system in Houston,
Texas to provide Implementation Project Management and consulting services.
During 2008 and the first quarter of 2009, we experienced an increase in revenue
from this line of business and anticipate a continuing relationship with this
Healthcare system. During the second and third quarters of 2008 we entered into
contracts with healthcare related systems in Texas, Illinois and California to
provide similar services. We will continue to put particular focus on the
delivery of Implementation Project Management services to the growing Healthcare
industry.
Application
Development
Throughout
2007 we completed certain application development engagements which resulted in
a decrease in both revenue and corresponding contractor expenses during 2008 and
early 2009. We are currently pursuing multiple opportunities to expand this
practice area.
LIQUIDITY
AND CAPITAL RESOURCES
Operations
for the three months ended March 31, 2009 have been funded by loans from a
related party. Bluegate has continued to take steps to reduce its monthly
operating expenses relating to its core business and has expanded its efforts in
creating a market for its Professional Services organization.
As of
March 31, 2009, our cash and cash equivalents were $79,448; total current assets
were $583,226, total current liabilities were $2,196,735 and total stockholders’
deficit was $1,578,038. Effective January 1, 2008, three of the company’s
executive officers reduced their annual base salaries to $100,000 each (which
were further reduced to $24,000 effective May 1, 2008) until the company
achieves a net positive cash flow from operations.
We intend
to use debt to cover the anticipated negative cash flow into the second quarter
of 2009, at which time we project to be operating at a break-even cash flow
mode. We are seeking additional capital to fund potential costs
associated with expansion and/or acquisitions. We believe that future funding
may be obtained from public or private offerings of equity securities, debt or
convertible debt securities or other sources. Stockholders should assume that
any additional funding will likely be dilutive.
Our
ability to achieve profitability will depend upon our ability to execute and
deliver high quality, reliable connectivity services, expand participation in
our Medical Grade Network® and grow our Professional Service
organization.
Our
growth is dependent on attaining profit from our operations and our raising
additional capital either through the sale of stock or
borrowing. There is no assurance that we will be able to raise any
equity financing or sell any of our products at a profit.
Our
future capital requirements will depend upon many factors, including the
following:
-
|
The
cost of operating delivering the Medical Grade Network®
services
|
-
|
The
cost of sales and marketing
|
-
|
The
rate at which we expand our
operations
|
-
|
Attractive
acquisition opportunities
|
-
|
The
response of competitors
|
-
|
Capital
expenditures
|
I-6
ITEM 4. CONTROLS AND PROCEDURES
|
(a)
Evaluation of disclosure controls and
procedures.
|
The
Company’s Chief Executive Officer and Principal Accounting Officer participated
in an evaluation by management of the effectiveness of the Company’s disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) as of March 31, 2009. Based on their participation in that
evaluation, the Company’s Chief Executive Officer and Principal Accounting
Officer concluded that the Company’s disclosure controls and procedures were
effective as of March 31, 2009 to ensure that required information is disclosed
on a timely basis in its reports filed or furnished under the Exchange
Act.
(b)
Changes in internal control over financial reporting.
There was
no change in the Company’s internal control over financial reporting (as defined
in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the quarter
ended March 31, 2009 that has materially affected, or is reasonably likely to
materially affect, the Company’s internal control over financial
reporting.
I-7
PART II. OTHER INFORMATION
ITEM
1. LEGAL
PROCEEDINGS
NONE.
NONE.
ITEM
5. OTHER
INFORMATION
NONE
ITEM
6. EXHIBITS
Exhibit
|
|
Number
|
Name
|
31.1
|
CERTIFICATION
REQUIRED BY RULE 13a - 14(a) OR RULE 15d - 14(a) OF THE SECURITIES
EXCHANGE ACT
OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT
OF 2002 OF THE CHIEF EXECUTIVE OFFICER
|
31.2
|
CERTIFICATION
REQUIRED BY RULE 13a - 14(a) OR RULE 15d - 14(a) OF THE SECURITIES
EXCHANGE ACT
OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT
OF 2002 OF THE CHIEF FINANCIAL OFFICER AND PRINCIPAL ACCOUNTING
OFFICER
|
32.1
|
CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C.
SECTION 1350), OF THE CHIEF EXECUTIVE OFFICER
|
32.2
|
CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C.
SECTION 1350), OF THE CHIEF FINANCIAL OFFICER AND PRINCIPAL ACCOUNTING
OFFICER
|
II-1
SIGNATURES
|
|||
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
|
|||
Bluegate
Corporation
|
|||
Date:
|
April 24,
2009
|
/s/
|
Stephen
J. Sperco
|
Stephen
J. Sperco,
|
|||
Chief
Executive Officer
|
|||
Bluegate
Corporation
|
|||
Date:
|
April 24,
2009
|
/s/
|
Charles
E. Leibold
|
Charles
E. Leibold,
|
|||
Chief
Financial Officer and Principal Accounting Officer
|
|||
II-2